Joyce Marques de Almeida
Overview
Explore the profile of Joyce Marques de Almeida including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
38
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Forestieri G, de Almeida J, Napoli S, Piffaretti D, Tarantelli C, Zhang F, et al.
Hematol Oncol
. 2024 Apr;
42(3):e3275.
PMID: 38650582
No abstract available.
2.
Aiello T, Salmanton-Garcia J, Marchesi F, Weinbergerova B, Glenthoj A, van Praet J, et al.
Haematologica
. 2024 Apr;
109(8):2693-2700.
PMID: 38572549
No abstract available.
3.
Salmanton-Garcia J, Marchesi F, Farina F, Weinbergerova B, Itri F, Davila-Valls J, et al.
EClinicalMedicine
. 2024 Mar;
71:102553.
PMID: 38533127
Background: The COVID-19 pandemic heightened risks for individuals with hematological malignancies due to compromised immune systems, leading to more severe outcomes and increased mortality. While interventions like vaccines, targeted antivirals,...
4.
van Doesum J, Salmanton-Garcia J, Marchesi F, Di Blasi R, Falces-Romero I, Cabirta A, et al.
Blood Adv
. 2023 Apr;
7(11):2645-2655.
PMID: 37058479
Patients with previous CD19-directed chimeric antigen receptor (CAR) T-cell therapy have a prolonged vulnerability to viral infections. Coronavirus disease 2019 (COVID-19) has a great impact and has previously been shown...
5.
Salmanton-Garcia J, Marchesi F, Gomes Da Silva M, Farina F, Davila-Valls J, Bilgin Y, et al.
EClinicalMedicine
. 2023 Apr;
58:101939.
PMID: 37041967
Background: Nirmatrelvir/ritonavir treatment decreases the hospitalisation rate in immunocompetent patients with COVID-19, but data on efficacy in patients with haematological malignancy are scarce. Here, we describe the outcome of nirmatrelvir/ritonavir...
6.
Forestieri G, di Bergamo L, Deodato M, Frustaci A, Moia R, Deambrogi C, et al.
Hematol Oncol
. 2022 May;
40(5):1100-1104.
PMID: 35613703
No abstract available.
7.
Rossi D, de Almeida J
Lancet Haematol
. 2021 Nov;
8(12):e864-e865.
PMID: 34826404
No abstract available.
8.
Barbosa B, de Almeida J, Barbosa M, Rossi-Barbosa L
Cien Saude Colet
. 2014 Aug;
19(8):3317-25.
PMID: 25119071
The scope of this study was to evaluate the functional capacity and analyze the characteristics associated with the disability of elderly individuals attended in a Family Health Strategy Unit in...